Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Corticosteroid treatment, serum lipids and coronary artery disease.

Literature DB >> 7443604

Corticosteroid treatment, serum lipids and coronary artery disease.

Abstract

Serum lipids and the cholesterol concentrations in the high density lipoprotein (HDL) fractions were measured in patients receiving long-term corticosteroid treatment for connective tissue disorders and asthma. Patients who were not receiving corticosteroid treatment had blood lipid levels which did not differ from those of healthy people. However, female (but not male) patients who had received prednisolone for a mean period of 3.1 years had a significant elevation in total cholesterol and a large decrease in HDL cholesterol. It seems possible that high levels of corticosteroids may increase the incidence of premenopausal ischaemic heart disease in females.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1980 PMID： 7443604 PMCID： PMC2425829 DOI： 10.1136/pgmj.56.657.491

Source DB: PubMed Journal: Postgrad Med J ISSN： 0032-5473 Impact factor: 2.401

9 in total

1. High-density lipoprotein in chronic renal failure and after renal transplantation.

Authors: E Savdie; J C Gibson; J H Stewart; L A Simons
Journal: Br Med J Date: 1979-04-07

2. Plasma lipoproteins in renal transplant patients.

Authors: D B Evans; P Ghosh
Journal: Br Med J Date: 1979-01-06

3. Hyperlipidaemia in asthmatic patients receiving long-term steroid therapy.

Authors: A H el-Shaboury; T M Hayes
Journal: Br Med J Date: 1973-04-14

4. Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy.

Authors: K Kalbak
Journal: Ann Rheum Dis Date: 1972-05 Impact factor: 19.103

5. Association between oral contraceptives and myocardial infarction. A review.

Authors: H W Ory
Journal: JAMA Date: 1977-06-13 Impact factor: 56.272

6. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients.

Authors: B H Bulkley; W C Roberts
Journal: Am J Med Date: 1975-02 Impact factor: 4.965

7. Serum high density lipoprotein in diabetic patients.

Authors: M F Lopes-Virella; P G Stone; J A Colwell
Journal: Diabetologia Date: 1977-08 Impact factor: 10.122

8. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors: T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal: Am J Med Date: 1977-05 Impact factor: 4.965

9. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

Authors: N E Miller; D S Thelle; O H Forde; O D Mjos
Journal: Lancet Date: 1977-05-07 Impact factor: 79.321

9 in total

6 in total

1. Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile.

Authors: G Mazzella; P Fusaroli; A Pezzoli; F Azzaroli; C Mazzeo; L Zambonin; P Simoni; D Festi; E Roda
Journal: Dig Dis Sci Date: 1999-12 Impact factor: 3.199

Corticosteroid treatment, serum lipids and coronary artery disease.

1. High-density lipoprotein in chronic renal failure and after renal transplantation.

2. Plasma lipoproteins in renal transplant patients.

3. Hyperlipidaemia in asthmatic patients receiving long-term steroid therapy.

4. Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy.

5. Association between oral contraceptives and myocardial infarction. A review.

6. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients.

7. Serum high density lipoprotein in diabetic patients.

8. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

9. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

1. Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile.

Review 2. Corticosteroid-induced adverse events in adults: frequency, screening and prevention.

3. Steroid induced hypertriglyceridemia in pregnant waman with immune thrombocytopenia - case report.

Review 4. Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.

Review 5. Haematological Drugs Affecting Lipid Metabolism and Vascular Health.

6. Niacin Ameliorates Lipid Disturbances due to Glucocorticoid Administration in Rats.